DNA-Encoded Libraries for the Discovery of Small-Molecule Hits
Drug Discovery Chemistry Conference 2023
DNA-Encoded library (DEL) screening is now commonly used in the pharmaceutical industry to find novel chemical matter that modulates protein targets of interest. Point-by-point, Dr. Alex Satz, Executive Director, WuXi Biology will discuss the primary challenges and limitations of DEL screening, and concisely state the current abilities of the technology and its potential.
Discover our end-to-end solutions platform for DEL screening.
Related Content
In this webinar, WuXi AppTec scientists discuss the latest innovative technologies and products in early-stage drug discovery. Viewers will gain...
VIEW RESOURCEDNA-encoded library (DEL) technology has been recognized as a major screening method, offering unique advantages through its ability to provide...
VIEW RESOURCE